Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual.

Katja Steinbrücker; Elke Tiefenthaler; Eva-Maria Schernthaner; Julia Jungwirth; Saskia Wortmann

doi:10.1055/a-1959-9404

Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual.

Katja Steinbrücker (Erstautor/-in), Elke Tiefenthaler, Eva-Maria Schernthaner, Julia Jungwirth, Saskia Wortmann (Letztautor/-in)

Universitätsklinik für Kinder- und Jugendheilkunde

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

4 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	78-81
Seitenumfang	4
Fachzeitschrift	NEUROPEDIATRICS
Jahrgang	54
Ausgabenummer	1
Frühes Online-Datum	12 Okt. 2022
DOIs	https://doi.org/10.1055/a-1959-9404
Publikationsstatus	Veröffentlicht - Feb. 2023

Zugriff auf Dokument

10.1055/a-1959-9404

Dieses zitieren

Steinbrücker, K., Tiefenthaler, E., Schernthaner, E.-M., Jungwirth, J., & Wortmann, S. (2023). Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual. NEUROPEDIATRICS , 54(1), 78-81. https://doi.org/10.1055/a-1959-9404

Steinbrücker, Katja ; Tiefenthaler, Elke ; Schernthaner, Eva-Maria et al. / Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual. in: NEUROPEDIATRICS 2023 ; Jahrgang 54, Nr. 1. S. 78-81.

@article{476e3ec704564be6a80028f62371cc8e,

title = "Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual.",

keywords = "Humans, Adolescent, Child, Preschool, Ataxia Telangiectasia/drug therapy, Niacinamide/therapeutic use, Pyridinium Compounds, Ataxia",

author = "Katja Steinbr{\"u}cker and Elke Tiefenthaler and Eva-Maria Schernthaner and Julia Jungwirth and Saskia Wortmann",

year = "2023",

month = feb,

doi = "10.1055/a-1959-9404",

language = "English",

volume = "54",

pages = "78--81",

journal = "NEUROPEDIATRICS ",

publisher = "Thieme Medical Publishers, US ",

number = "1",

}

Steinbrücker, K, Tiefenthaler, E, Schernthaner, E-M, Jungwirth, J & Wortmann, S 2023, 'Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual.', NEUROPEDIATRICS , Jg. 54, Nr. 1, S. 78-81. https://doi.org/10.1055/a-1959-9404

Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual. / Steinbrücker, Katja (Erstautor/-in); Tiefenthaler, Elke; Schernthaner, Eva-Maria et al.
in: NEUROPEDIATRICS , Jahrgang 54, Nr. 1, 02.2023, S. 78-81.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual.

AU - Steinbrücker, Katja

AU - Tiefenthaler, Elke

AU - Schernthaner, Eva-Maria

AU - Jungwirth, Julia

AU - Wortmann, Saskia

PY - 2023/2

Y1 - 2023/2

KW - Humans

KW - Adolescent

KW - Child, Preschool

KW - Ataxia Telangiectasia/drug therapy

KW - Niacinamide/therapeutic use

KW - Pyridinium Compounds

KW - Ataxia

U2 - 10.1055/a-1959-9404

DO - 10.1055/a-1959-9404

M3 - Original Article

C2 - 36223879

VL - 54

SP - 78

EP - 81

JO - NEUROPEDIATRICS

JF - NEUROPEDIATRICS

IS - 1

ER -

Steinbrücker K, Tiefenthaler E, Schernthaner EM, Jungwirth J, Wortmann S. Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual. NEUROPEDIATRICS . 2023 Feb;54(1):78-81. Epub 2022 Okt 12. doi: 10.1055/a-1959-9404